Free Trial

Cooper Companies (NASDAQ:COO) Price Target Lowered to $105.00 at Stifel Nicolaus

Cooper Companies logo with Medical background
Remove Ads

Cooper Companies (NASDAQ:COO - Free Report) had its price objective reduced by Stifel Nicolaus from $115.00 to $105.00 in a research note issued to investors on Friday, MarketBeat.com reports. They currently have a buy rating on the medical device company's stock.

Several other brokerages also recently issued reports on COO. StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday. Citigroup reduced their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday. Finally, Wells Fargo & Company increased their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, Cooper Companies presently has an average rating of "Moderate Buy" and an average target price of $111.89.

Remove Ads

Check Out Our Latest Report on COO

Cooper Companies Stock Up 1.4 %

COO stock traded up $1.14 during mid-day trading on Friday, reaching $81.03. The company had a trading volume of 3,370,815 shares, compared to its average volume of 1,725,305. The company has a market capitalization of $16.17 billion, a price-to-earnings ratio of 41.55, a PEG ratio of 2.25 and a beta of 1.02. Cooper Companies has a 52 week low of $78.43 and a 52 week high of $112.38. The stock has a 50 day simple moving average of $91.93 and a two-hundred day simple moving average of $99.25. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities analysts predict that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Institutional Trading of Cooper Companies

Hedge funds and other institutional investors have recently bought and sold shares of the business. Ashton Thomas Securities LLC acquired a new stake in shares of Cooper Companies in the third quarter valued at approximately $25,000. Covestor Ltd increased its stake in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after acquiring an additional 200 shares during the period. Byrne Asset Management LLC acquired a new position in Cooper Companies in the 4th quarter valued at $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies during the 4th quarter valued at $34,000. Finally, New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth $38,000. Institutional investors and hedge funds own 24.39% of the company's stock.

About Cooper Companies

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads